Agios Pharmaceuticals Inc (AGIO) returns
Agios Pharmaceuticals returns over 10 years
$1,000 invested in Agios Pharmaceuticals ten years ago was worth $628.86 at the close on October 30, 2026, with dividends reinvested: an average return of -4.5% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -8.1% | — | $918.80 | -0.9% |
| 3 months | -6.7% | — | $932.82 | +2.1% |
| Year to date | +12.2% | — | $1,122 | +11.7% |
| 1 year | -29.2% | — | $707.50 | +12.4% |
| 3 years | +49.8% | +14.4% | $1,498 | +88.5% |
| 5 years | -35.0% | -8.3% | $650.00 | +76.0% |
| 10 years | -37.1% | -4.5% | $628.86 | +316.6% |
Agios Pharmaceuticals return by calendar year
| Year | AGIO | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +12.2% | +11.7% | +0.5% |
| 2025 | -17.2% | +17.7% | -34.9% |
| 2024 | +47.6% | +24.9% | +22.7% |
| 2023 | -20.7% | +26.2% | -46.9% |
| 2022 | -14.6% | -18.2% | +3.6% |
| 2021 | -24.1% | +28.7% | -52.9% |
| 2020 | -9.3% | +18.4% | -27.6% |
| 2019 | +3.6% | +31.2% | -27.7% |
| 2018 | -19.3% | -4.6% | -14.8% |
| 2017 | +37.0% | +21.7% | +15.3% |
| 2016 | -35.7% | +12.0% | -47.7% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: AGIO financials
No forecast, no recommendation. This page describes Agios Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.